Nitric Oxide Lung Diffusing Capacity in Healthy, Non-smoking Adults

University of Zurich35 enrolled

Overview

The measurement of nitric oxide lung diffusing capacity (DLNO) has been recently standardised. To date, two pulmonary function devices are commercially available and are used for the measurement of DLNO. No previous study assessed differences in gas exchange outcomes (e.g., DLNO values) between both devices. The aim of this project is to compare two commercially available devices that measure lung diffusing capacity for nitric oxide (DLNO). 1. "MasterScreenTM" (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany 2. "HypAir" ("HA", Medisoft, Dinant, Belgium).

In a single-center, crossover study conducted at the University Hospital Zurich, Switzerland, 35 healthy, non-smoking adults (\>=18 years) will be invited to perform DLNO measurements in random order using the MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium) devices during one study visit. The order of the tests on the MasterscreenTM and HypAir devices will be randomly allocated using central randomisation.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Healthy

Interventions

Jaeger Masterscreen TMDEVICE

Single-breath nitric oxide lung diffusing capacity

HypAir MedisoftDEVICE

Single-breath nitric oxide lung diffusing capacity

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: \- Age 18 years and older Exclusion Criteria: * Previous thoracic surgery * Smoking * Chronic lung disease (e.g., asthma bronchiale, COPD) * Forced expiratory volume in 1s and/or forced vital capacity below the lower limit of normal based on spirometry \[Quanjer et al. Eur Respir J 2005\] * Current respiratory infection

Locations (1)

University of Zurich and University Hospital of Zurich

Zurich, Switzerland